Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Neuromuscular Disorders : NMD|September 11, 2016
Phosphoglycerate mutase deficiency (glycogen storage disease X) caused by a novel variant in PGAM-MBenjamin Koo, Bjorn OskarssonPhysical Medicine and Rehabilitation Clinics of North America|November 10, 2012
Current pharmacologic management in selected neuromuscular diseasesAndrew J Skalsky, Bjorn Oskarsson, Jay J Han, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|November 5, 2016
Longitudinal evaluation of upper extremity reachable workspace in ALS by Kinect sensorEvan de Bie, Bjorn Oskarsson, Nanette C Joyce, et al.Muscle & Nerve|May 13, 2015
Upper extremity 3-dimensional reachable workspace assessment in amyotrophic lateral sclerosis by Kinect sensorBjorn Oskarsson, Nanette C Joyce, Evan De Bie, et al.Neurology|May 3, 2013
Motor neuron involvement in multisystem proteinopathy: implications for ALSMichael Benatar, Joanne Wuu, Catalina Fernandez, et al.Archives of Neurology|April 18, 2012
Treatment of γ-aminobutyric acid B receptor-antibody autoimmune encephalitis with oral corticosteroidsDaniel M Goldenholz, Victoria S S Wong, Lisa M Bateman, et al.Muscle & Nerve|January 31, 2022
Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre-specified and post hoc analysesRobert G Miller, Rongzhen Zhang, Paige M Bracci, et al.Behavioural Neurology|December 6, 2018
Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS PatientsSusan Woolley, Ray Goetz, Pam Factor-Litvak, et al.Behavioural Neurology|December 31, 2019
Corrigendum to "Longitudinal Screening Detects Cognitive Stability and Behavioral Deterioration in ALS Patients"Susan Woolley, Ray Goetz, Pam Factor-Litvak, et al.Nature Medicine|June 27, 2018
Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosisYong-Jie Zhang, Tania F Gendron, Mark T W Ebbert, et al.Pageof 2